Perioperative Aspirin Usage Survey
- Conditions
- SurgeryCardiovascular Disease
- Interventions
- Behavioral: Survey
- Registration Number
- NCT02561507
- Lead Sponsor
- University of New Mexico
- Brief Summary
This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.
- Detailed Description
An announcement of the survey and invitation to participate will be posted in the "ACS Surgery News" newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc.
The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 150
- Members of the American College of Surgeons
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description American College of Surgeons members Survey Survey participants
- Primary Outcome Measures
Name Time Method Typical proportion of participants' patients given a recommendation to stop taking aspirin At time of survey; generally less than 20 minutes Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations At time of survey; generally less than 20 minutes Proportion of participants correctly answering questions about platelet rebound effect At time of survey; generally less than 20 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of New Mexico Hospital
🇺🇸Albuquerque, New Mexico, United States